Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rulemaking For OTC Switch Process Changes Pushed To 2019

Executive Summary

Target date moved from August 2018 to February 2019 for publishing an NPRM for allowing currently Rx drug ingredients to be available nonprescription under conditions of safe use. US HHS annual spring update on regulatory priorities for FDA and its other agencies also pushes back target dates for other OTC drug NPRMs, including FDA's long-delayed finalization of several monographs including sunscreen ingredients.

Advertisement

Related Content

Another Change At Perrigo Helm As Results Remain Turbulent
FDA OTC Switch Guidance Omits Some Turns As Approval Roadmap, CHPA Says
Innovation In OTC Switches Takes Multimedia Approach In US FDA Draft Guidance
OTC Monograph Bill Has Energy And Commerce Date, CDER Director's Hope
Smoking Cessation Indication For E-Cigarettes Could Fade Under Cloud Of Nicotine Packaged For Children
HHS Regulatory Agenda Omits Drug Pricing Actions – Unless OTC Switches Still Count
Tests On Professional Antiseptics Could Influence Consumer Hand Wash Market

Topics

Advertisement
UsernamePublicRestriction

Register

PS123269

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel